| Demand forecasting in food retail: A comparison between the Holt-Winters and ARIMA models CP Da Veiga, CRP Da Veiga, A Catapan, U Tortato, WV Da Silva WSEAS transactions on business and economics 11 (1), 608-614, 2014 | 125 | 2014 |
| Demand forecasting based on natural computing approaches applied to the foodstuff retail segment CP da Veiga, CRP da Veiga, W Puchalski, L dos Santos Coelho, ... Journal of Retailing and Consumer Services 31, 174-181, 2016 | 59 | 2016 |
| Concern over cost of and access to cancer treatments: a meta-narrative review of nivolumab and pembrolizumab studies CRP da Veiga, CP da Veiga, AP Drummond-Lage Critical reviews in oncology/hematology 129, 133-145, 2018 | 34 | 2018 |
| Facebook HPV vaccine campaign: insights from Brazil CR Pereira da Veiga, E Semprebon, JL da Silva, V Lins Ferreira, ... Human vaccines & immunotherapeutics 16 (8), 1824-1834, 2020 | 17 | 2020 |
| Social media analysis to understand the expected benefits by plant-based meat alternatives consumers MNB Moreira, CRP da Veiga, Z Su, GG Reis, LM Pascuci, CP da Veiga Foods 10 (12), 3144, 2021 | 16 | 2021 |
| A acuracidade dos modelos de previsão de demanda como fator crítico para o desempenho financeiro na indústria de alimentos CRP Da Veiga, CP Da Veiga, LC Duclós Future Studies Research Journal: Trends and Strategies 2 (2), 83-107, 2010 | 16 | 2010 |
| The accuracy of demand forecast models as a critical factor in the financial performance of the food industry CRP da Veiga, CP da Veiga, LC Duclós Future Studies Research Journal 2 (2), 81-104, 2010 | 16 | 2010 |
| Reducing meat consumption: Insights from a bibliometric analysis and future scopes MNB Moreira, CP da Veiga, CRP da Veiga, GG Reis, LM Pascuci Future Foods 5, 100120, 2022 | 15 | 2022 |
| Generic drugs in times of economic crisis: Are there changes in consumer purchase intention? VL Ferreira, CRP da Veiga, C Kudlawicz-Franco, P Scalercio, Y Ramires, ... Journal of Retailing and Consumer Services 37, 1-7, 2017 | 15 | 2017 |
| The different phases of the omnichannel consumer buying journey: a systematic literature review and future research directions TSG Furquim, CP Da Veiga, CRP Veiga, WV Silva Journal of Theoretical and Applied Electronic Commerce Research 18 (1), 79-104, 2022 | 13 | 2022 |
| Cutaneous melanoma: cost of illness under Brazilian health system perspectives CRP da Veiga, CP da Veiga, A Souza, AJA Wainstein, AC de Melo, ... BMC health services research 21, 1-14, 2021 | 10 | 2021 |
| Attitude and purchase intention to generic drugs R Arcaro, CRP da Veiga, WV da Silva, C Pereira da Veiga International Journal of Environmental Research and Public Health 18 (9), 4579, 2021 | 10 | 2021 |
| Dengue vaccines: a perspective from the point of view of intellectual property C Pereira da Veiga, CR Pereira da Veiga, JM Del Corso, ... International journal of environmental research and public health 12 (8 …, 2015 | 10 | 2015 |
| Evolution of capabilities in the discovery cycle of an innovation in the pharmaceutical market CP Da Veiga, CRP Da Veiga, MM Giacomini, HT Kato, JM Del Corso International Review of Management and Marketing 5 (3), 141-153, 2015 | 10 | 2015 |
| Estratégia de planejamento do sortimento: Um estudo de caso do varejo de alimentos no Brasil CP Da Veiga, CRP Da Veiga, KH Sato, U Tortato Revista Administração em Diálogo 13 (1), 1-24, 2011 | 10 | 2011 |
| Vaccine R&D in Brazil: The effectiveness of push and pull regulations CRP da Veiga, CP da Veiga, JM Del Corso, WV da Silva World Patent Information 46, 11-18, 2016 | 7 | 2016 |
| Demand forecasting strategies: Understanding the most important concepts CP da VEIGA, CRP da VEIGA, U TORTATO Revista ESPACIOS| Vol. 37 (Nº 05) Año 2016, 2016 | 7 | 2016 |
| Institutional theory and resource dependency in the alteration of distribution channels CRP Veiga, CP Veiga, A Catapan, U Tortato, WV Silva, AKG Leinig Int. Bus. Manage 8, 240-250, 2014 | 7 | 2014 |
| After-sales attributes in E-commerce: A systematic literature review and future research agenda RM Ferraz, CP Da Veiga, CRP da Veiga, TSG Furquim, WV da Silva Journal of theoretical and applied electronic commerce research 18 (1), 475-500, 2023 | 6 | 2023 |
| Pembrolizumab plus axitinib and nivolumab plus ipilimumab as first-line treatments of advanced intermediate-or poor-risk renal-cell carcinoma: a number needed to treat analysis … T Engel Ayer Botrel, M Datz Abadi, L Chabrol Haas, CRP da Veiga, ... Journal of Medical Economics 24 (1), 291-298, 2021 | 6 | 2021 |
